Since TNFα inhibitors, such as infliximab, etanercept, and adalimumab, are effective in RA and other autoimmune diseases (Lim et al., 2018), metformin's anti‐TNFα function could be effective in these diseases. This evidence concerns the gene TNF and rheumatoid arthritis.